ID   SPS1_HUMAN              Reviewed;         392 AA.
AC   P49903; B4DWK0; D3DRS9; D6PSQ9; Q5T5U8; Q5T5U9; Q9BVT4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   13-DEC-2002, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Selenide, water dikinase 1;
DE            EC=2.7.9.3;
DE   AltName: Full=Selenium donor protein 1;
DE   AltName: Full=Selenophosphate synthase 1;
GN   Name=SEPHS1; Synonyms=SELD, SPS, SPS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ATP-BINDING, AND
RP   MUTAGENESIS OF GLY-268; GLY-270; GLY-273 AND HIS-274.
RC   TISSUE=Liver;
RX   PubMed=7665581; DOI=10.1074/jbc.270.37.21659;
RA   Low S.C., Harney J.W., Berry M.J.;
RT   "Cloning and functional characterization of human selenophosphate
RT   synthetase, an essential component of selenoprotein synthesis.";
RL   J. Biol. Chem. 270:21659-21664(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20471958; DOI=10.1016/j.bbrc.2010.05.055;
RA   Kim J.Y., Lee K.H., Shim M.S., Shin H., Xu X.M., Carlson B.A.,
RA   Hatfield D.L., Lee B.J.;
RT   "Human selenophosphate synthetase 1 has five splice variants with
RT   unique interactions, subcellular localizations and expression
RT   patterns.";
RL   Biochem. Biophys. Res. Commun. 397:53-58(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 5-16 AND 64-76, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH ADP; MAGNESIUM
RP   IONS AND PHOSPHATE, SUBUNIT, ENZYME REGULATION, AND MUTAGENESIS OF
RP   THR-85.
RX   PubMed=19477186; DOI=10.1016/j.jmb.2009.05.032;
RA   Wang K.T., Wang J., Li L.F., Su X.D.;
RT   "Crystal structures of catalytic intermediates of human
RT   selenophosphate synthetase 1.";
RL   J. Mol. Biol. 390:747-759(2009).
CC   -!- FUNCTION: Synthesizes selenophosphate from selenide and ATP.
CC       {ECO:0000269|PubMed:7665581}.
CC   -!- CATALYTIC ACTIVITY: ATP + selenide + H(2)O = AMP + selenophosphate
CC       + phosphate.
CC   -!- ENZYME REGULATION: Activated by phosphate ions and by potassium
CC       ions. {ECO:0000269|PubMed:19477186}.
CC   -!- SUBUNIT: Homodimer (isoform 1, isoform 2, isoform 3 and isoform
CC       4). Heterodimer of isoform 1 and isoform 3. Heterodimer of isoform
CC       2 and isoform 4. {ECO:0000269|PubMed:19477186,
CC       ECO:0000269|PubMed:20471958}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-714091, EBI-714091;
CC       Q2TAL8:QRICH1; NbExp=9; IntAct=EBI-714091, EBI-2798044;
CC       P24278:ZBTB25; NbExp=8; IntAct=EBI-714091, EBI-739899;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane. Nucleus membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Major type, MT;
CC         IsoId=P49903-1; Sequence=Displayed;
CC       Name=2; Synonyms=Delta E8;
CC         IsoId=P49903-2; Sequence=VSP_046702;
CC       Name=3; Synonyms=Delta E2;
CC         IsoId=P49903-3; Sequence=VSP_046701;
CC       Name=4; Synonyms=E9 and E9a;
CC         IsoId=P49903-4; Sequence=VSP_047451;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are gradually
CC       expressed during the cell cycle until G2/M phase and then
CC       decreased. Isoform 3 is gradually expressed during the cell cycle
CC       until S phase and then decreased. {ECO:0000269|PubMed:20471958}.
CC   -!- SIMILARITY: Belongs to the selenophosphate synthase 1 family.
CC       Class II subfamily. {ECO:0000305}.
CC   -!- CAUTION: The conserved active site Cys (or selenocysteine) residue
CC       in position 29 is replaced by a Thr. However, as function in
CC       selenoprotein synthesis is proven, it is possible Cys-31 is the
CC       active site. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA87567.1; Type=Frameshift; Positions=377; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U34044; AAA87567.1; ALT_FRAME; mRNA.
DR   EMBL; GU954545; ADF78120.1; -; mRNA.
DR   EMBL; GU954546; ADF78121.1; -; mRNA.
DR   EMBL; GU954547; ADF78122.1; -; mRNA.
DR   EMBL; GU954548; ADF78123.1; -; mRNA.
DR   EMBL; GU954549; ADF78124.1; -; mRNA.
DR   EMBL; AK301568; BAG63062.1; -; mRNA.
DR   EMBL; AL138764; CAI12907.1; -; Genomic_DNA.
DR   EMBL; AL355870; CAI12907.1; JOINED; Genomic_DNA.
DR   EMBL; AL355870; CAI14198.1; -; Genomic_DNA.
DR   EMBL; AL138764; CAI14198.1; JOINED; Genomic_DNA.
DR   EMBL; CH471072; EAW86289.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86290.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86291.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86292.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86293.1; -; Genomic_DNA.
DR   EMBL; BC000941; AAH00941.1; -; mRNA.
DR   EMBL; BC063816; AAH63816.1; -; mRNA.
DR   CCDS; CCDS55702.1; -. [P49903-3]
DR   CCDS; CCDS55703.1; -. [P49903-2]
DR   CCDS; CCDS7098.1; -. [P49903-1]
DR   RefSeq; NP_001182531.1; NM_001195602.1. [P49903-3]
DR   RefSeq; NP_001182533.1; NM_001195604.1. [P49903-2]
DR   RefSeq; NP_036379.2; NM_012247.4. [P49903-1]
DR   RefSeq; XP_016871431.1; XM_017015942.1. [P49903-1]
DR   RefSeq; XP_016871432.1; XM_017015943.1. [P49903-1]
DR   RefSeq; XP_016871434.1; XM_017015945.1. [P49903-3]
DR   UniGene; Hs.124027; -.
DR   PDB; 3FD5; X-ray; 1.90 A; A/B=1-392.
DR   PDB; 3FD6; X-ray; 1.95 A; A/B=1-392.
DR   PDBsum; 3FD5; -.
DR   PDBsum; 3FD6; -.
DR   ProteinModelPortal; P49903; -.
DR   SMR; P49903; -.
DR   BioGrid; 116589; 51.
DR   IntAct; P49903; 14.
DR   STRING; 9606.ENSP00000367893; -.
DR   iPTMnet; P49903; -.
DR   PhosphoSitePlus; P49903; -.
DR   BioMuta; SEPHS1; -.
DR   DMDM; 27151792; -.
DR   EPD; P49903; -.
DR   MaxQB; P49903; -.
DR   PaxDb; P49903; -.
DR   PeptideAtlas; P49903; -.
DR   PRIDE; P49903; -.
DR   DNASU; 22929; -.
DR   Ensembl; ENST00000327347; ENSP00000367893; ENSG00000086475. [P49903-1]
DR   Ensembl; ENST00000378614; ENSP00000367877; ENSG00000086475. [P49903-2]
DR   Ensembl; ENST00000545675; ENSP00000441119; ENSG00000086475. [P49903-3]
DR   GeneID; 22929; -.
DR   KEGG; hsa:22929; -.
DR   UCSC; uc001imk.4; human. [P49903-1]
DR   CTD; 22929; -.
DR   DisGeNET; 22929; -.
DR   GeneCards; SEPHS1; -.
DR   HGNC; HGNC:19685; SEPHS1.
DR   HPA; HPA037645; -.
DR   MIM; 600902; gene.
DR   neXtProt; NX_P49903; -.
DR   OpenTargets; ENSG00000086475; -.
DR   PharmGKB; PA134905215; -.
DR   eggNOG; KOG3939; Eukaryota.
DR   eggNOG; COG0709; LUCA.
DR   GeneTree; ENSGT00390000000950; -.
DR   HOGENOM; HOG000219301; -.
DR   HOVERGEN; HBG001207; -.
DR   InParanoid; P49903; -.
DR   KO; K01008; -.
DR   OMA; DKNFRLT; -.
DR   OrthoDB; EOG091G0B7N; -.
DR   PhylomeDB; P49903; -.
DR   TreeFam; TF313811; -.
DR   BRENDA; 2.7.9.3; 2681.
DR   EvolutionaryTrace; P49903; -.
DR   GeneWiki; Selenophosphate_synthetase_1; -.
DR   GenomeRNAi; 22929; -.
DR   PRO; PR:P49903; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000086475; -.
DR   CleanEx; HS_SEPHS1; -.
DR   ExpressionAtlas; P49903; baseline and differential.
DR   Genevisible; P49903; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; TAS:ProtInc.
DR   GO; GO:0005525; F:GTP binding; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004756; F:selenide, water dikinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   Gene3D; 3.30.1330.10; -; 1.
DR   Gene3D; 3.90.650.10; -; 2.
DR   InterPro; IPR010918; AIR_synth_C_dom.
DR   InterPro; IPR016188; PurM-like_N.
DR   InterPro; IPR004536; SPS/SelD.
DR   PANTHER; PTHR10256; PTHR10256; 1.
DR   Pfam; PF00586; AIRS; 1.
DR   Pfam; PF02769; AIRS_C; 1.
DR   PIRSF; PIRSF036407; Selenphspht_syn; 1.
DR   SUPFAM; SSF55326; SSF55326; 1.
DR   SUPFAM; SSF56042; SSF56042; 1.
DR   TIGRFAMs; TIGR00476; selD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Kinase; Membrane; Nucleotide-binding;
KW   Nucleus; Reference proteome; Selenium; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    392       Selenide, water dikinase 1.
FT                                /FTId=PRO_0000127648.
FT   NP_BIND      67     69       ATP.
FT   NP_BIND     162    164       ATP; shared with dimeric partner.
FT   NP_BIND     267    273       ATP.
FT   ACT_SITE     31     31       {ECO:0000255}.
FT   BINDING      32     32       ATP.
FT   BINDING      87     87       ATP.
FT   BINDING     110    110       ATP.
FT   SITE         32     32       Important for catalytic activity.
FT                                {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   VAR_SEQ       1     67       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:20471958}.
FT                                /FTId=VSP_046701.
FT   VAR_SEQ     251    321       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:20471958}.
FT                                /FTId=VSP_046702.
FT   VAR_SEQ     322    392       GGLLICLPREQAARFCAEIKSPKYGEGHQAWIIGIVEKGNR
FT                                TARIIDKPRIIEVAPQVATQNVNPTPGATS -> DVQ (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:20471958}.
FT                                /FTId=VSP_047451.
FT   MUTAGEN      85     85       T->A: Strongly reduced ADP hydrolysis.
FT                                {ECO:0000269|PubMed:19477186}.
FT   MUTAGEN     268    268       G->C: No change in ATP-binding.
FT                                {ECO:0000269|PubMed:7665581}.
FT   MUTAGEN     270    270       G->R: No change in ATP-binding.
FT                                {ECO:0000269|PubMed:7665581}.
FT   MUTAGEN     273    273       G->A,D,V: Loss of ATP-binding.
FT                                {ECO:0000269|PubMed:7665581}.
FT   MUTAGEN     274    274       H->N: Reduced ATP-binding.
FT                                {ECO:0000269|PubMed:7665581}.
FT   MUTAGEN     274    274       H->Y: Increased ATP-binding.
FT                                {ECO:0000269|PubMed:7665581}.
FT   CONFLICT    260    260       A -> T (in Ref. 1; AAA87567).
FT                                {ECO:0000305}.
FT   HELIX        10     12       {ECO:0000244|PDB:3FD5}.
FT   HELIX        20     23       {ECO:0000244|PDB:3FD5}.
FT   HELIX        35     42       {ECO:0000244|PDB:3FD5}.
FT   STRAND       68     74       {ECO:0000244|PDB:3FD5}.
FT   STRAND       81     89       {ECO:0000244|PDB:3FD5}.
FT   HELIX        96    113       {ECO:0000244|PDB:3FD5}.
FT   STRAND      120    129       {ECO:0000244|PDB:3FD5}.
FT   HELIX       134    154       {ECO:0000244|PDB:3FD5}.
FT   STRAND      159    169       {ECO:0000244|PDB:3FD5}.
FT   STRAND      171    180       {ECO:0000244|PDB:3FD5}.
FT   HELIX       182    184       {ECO:0000244|PDB:3FD5}.
FT   STRAND      196    201       {ECO:0000244|PDB:3FD5}.
FT   HELIX       205    213       {ECO:0000244|PDB:3FD5}.
FT   HELIX       218    224       {ECO:0000244|PDB:3FD5}.
FT   HELIX       230    245       {ECO:0000244|PDB:3FD5}.
FT   HELIX       249    257       {ECO:0000244|PDB:3FD5}.
FT   STRAND      262    265       {ECO:0000244|PDB:3FD5}.
FT   HELIX       270    279       {ECO:0000244|PDB:3FD5}.
FT   STRAND      283    296       {ECO:0000244|PDB:3FD5}.
FT   HELIX       299    305       {ECO:0000244|PDB:3FD5}.
FT   TURN        306    308       {ECO:0000244|PDB:3FD5}.
FT   HELIX       312    314       {ECO:0000244|PDB:3FD5}.
FT   STRAND      324    328       {ECO:0000244|PDB:3FD5}.
FT   HELIX       330    341       {ECO:0000244|PDB:3FD5}.
FT   STRAND      352    362       {ECO:0000244|PDB:3FD5}.
FT   STRAND      364    375       {ECO:0000244|PDB:3FD5}.
SQ   SEQUENCE   392 AA;  42911 MW;  E9636E38146D926D CRC64;
     MSTRESFNPE SYELDKSFRL TRFTELKGTG CKVPQDVLQK LLESLQENHF QEDEQFLGAV
     MPRLGIGMDT CVIPLRHGGL SLVQTTDYIY PIVDDPYMMG RIACANVLSD LYAMGVTECD
     NMLMLLGVSN KMTDRERDKV MPLIIQGFKD AAEEAGTSVT GGQTVLNPWI VLGGVATTVC
     QPNEFIMPDN AVPGDVLVLT KPLGTQVAVA VHQWLDIPEK WNKIKLVVTQ EDVELAYQEA
     MMNMARLNRT AAGLMHTFNA HAATDITGFG ILGHAQNLAK QQRNEVSFVI HNLPVLAKMA
     AVSKACGNMF GLMHGTCPET SGGLLICLPR EQAARFCAEI KSPKYGEGHQ AWIIGIVEKG
     NRTARIIDKP RIIEVAPQVA TQNVNPTPGA TS
//
